abstract |
The present invention relates to sulfonamide derivativesnwherein R 1, R 2, R 3, R 4, R 5 and R 6 are specificnmeaning, their physiologically acceptable salts and their prodrugs.nThe compounds of formula I are valuable pharmaceuticallynwith active compounds. They are vitronectin antagonistsneptor and cell adhesion inhibitors and inhibit bone resorptionneoclasts. They are suitable, for example, for therapy and prophylaxisnnights caused by undesirable bone resorptionnosteoporosis. The invention further relates to a processngrasses of the compounds of formula I, their use, in particularnt of pharmaceutically active ingredients and pharmaceuticalsnwhich contain them. |